Amen side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Amen. Common side effects include ovarian cancer metastatic among females, and glomerulonephritis among males.

The phase IV clinical study is created by eHealthMe based on 93 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 04, 2023

93 people who take Amen and have side effects are studied.


What is Amen?

Amen has active ingredients of medroxyprogesterone acetate. Currently, eHealthMe is studying from 96 Amen users.

Number of Amen reports submitted per year:

Amen side effects.

Amen side effects by time on the drug*:

< 1 month:

  1. Pulmonary embolism (blockage of the main artery of the lung)

1 - 6 months:

  1. Pulmonary embolism (blockage of the main artery of the lung)

6 - 12 months:

n/a

1 - 2 years:

  1. Breast cancer

2 - 5 years:

  1. Breast cancer female
  2. Breast cancer
  3. Aortic valve disease
  4. Asthma
  5. Atrophic vulvovaginitis (inflammation of the vulva)
  6. Pulmonary embolism (blockage of the main artery of the lung)

5 - 10 years:

  1. Breast cancer female
  2. Breast cancer

10+ years:

  1. Breast cancer female
  2. Breast cancer

not specified:

  1. Breast cancer
  2. Breast cancer female
  3. Breast cancer metastatic
  4. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  5. Ovarian cancer (cancer of ovary)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts)
  8. Activities of daily living impaired
  9. Acute respiratory failure
  10. Anaemia (lack of blood)

Amen side effects by gender *:

female:

  1. Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts)
  2. Activities of daily living impaired
  3. Acute respiratory failure
  4. Aortic valve disease
  5. Arthralgia (joint pain)
  6. Asthma
  7. Blood cholesterol increased
  8. Breast cancer recurrent
  9. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  10. Feeling abnormal

male:

  1. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  2. Anaemia (lack of blood)
  3. Breast cancer female
  4. Drug hypersensitivity

Amen side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  2. Drug hypersensitivity

40-49:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatic necrosis (large portions of liver die off due to severe liver disease)

50-59:

  1. Breast cancer
  2. Breast cancer female
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Breast cancer metastatic
  5. Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts)
  6. Arthralgia (joint pain)
  7. Asthma
  8. Blood cholesterol increased
  9. Breast cancer recurrent
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

60+:

  1. Aortic valve disease
  2. Breast cancer female
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Breast cancer
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Activities of daily living impaired

* Approximation only. Some reports may have incomplete information.

Do you take Amen?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

How the study uses the data?

The study is based on medroxyprogesterone acetate (the active ingredients of Amen) and Amen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Amen:

All Amen side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: